Advertisement
-
-
The gut microbiota in thrombosis
The gut microbiota has emerged as a risk factor that affects thrombotic phenotypes in several cardiovascular diseases. In this Review, Reinhardt and colleagues discuss the link between the gut microbiota, its metabolites and thromboembolic diseases, and summarize potential therapeutic interventions to modulate the gut microbiota.
-
-
Anticoagulants
Anticoagulant drugs are used to prevent and treat thrombotic disorders in millions of patients worldwide. This Milestone plots the history of anticoagulant drugs, starting with the discovery and clinical trials of heparin and warfarin.
Trending - Altmetric
-
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
-
Viral myocarditis—diagnosis, treatment options, and current controversies
-
The LDL cumulative exposure hypothesis: evidence and practical applications
-
Inherited calcium channelopathies in the pathophysiology of arrhythmias